Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases

(2017) Ekaterina A. Ivanova et al.   Oxidative Medicine and Cellular Longevity

The Relationship Between Atherogenic Index and Carotid Artery Atherosclerosis in Familial Mediterranean Fever

(2016) Abdullah Icli et al.   ANGIOLOGY

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

(2016)   LANCET

Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease

(2016) E. Cure et al.   ZEITSCHRIFT FUR RHEUMATOLOGIE

Potential long-term effects of previous schistosome infection may reduce the atherogenic index of plasma in Chinese men

(2015) Shi-Wei Shen et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Cardiometabolic Risks and Severity of Obesity in Children and Young Adults

(2015) Asheley C. Skinner et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus

(2015) Xiao-Wei Zhu et al.   Primary Care Diabetes

Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan

(2014) Ritsuko Nishide et al.   Environmental Health and Preventive Medicine

Effect of Atorvastatin on Low-Density Lipoprotein Subpopulations and Comparison Between Indicators of Plasma Atherogenicity

(2013) Marek Kucera et al.   ANGIOLOGY

2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults

(2013) Neil J. Stone et al.   CIRCULATION

Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association

(2013) Harold E. Bays et al.   Journal of Clinical Lipidology

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL